Showing results (11-20 of 63) with videos related to
Sort By:
Pageof 7
Journal of the National Cancer Institute|May 18, 1988
New indirect approach to the therapeutic use of immunotoxinsO Fodstad, G Kvalheim, A Pihl, et al.British Journal of Cancer|October 25, 2000
Demonstration of highly specific toxicity of the alpha-emitting radioimmunoconjugate(211)At-rituximab against non-Hodgkin's lymphoma cellsE Aurlien, R H Larsen, G Kvalheim, et al.Therapeutic Drug Monitoring|January 1, 1985
Determination of warfarin in human plasma by high performance liquid chromatography and photodiode array detectorP M Ueland, G Kvalheim, P E Lønning, et al.Haematologica|March 1, 1991
Autologous transplantation of an immunomagnetic bead purged marrow in patients with relapsed acute lymphoblastic leukemiaM Körbling, W Knauf, S Funderud, et al.Cytotherapy|September 21, 2007
mRNA transfection of DC in the immature or mature state: comparable in vitro priming of Th and cytotoxic T lymphocytes against DC electroporated with tumor cell line-derived mRNAS Jarnjak-Jankovic, S Saebøe-Larssen, G Kvalheim, et al.Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|April 8, 2003
A survey of therapeutic hemapheresis in Norway year 2000E Taraldsrud, G Kvalheim, S Jørstad, et al.Shock (Augusta, Ga.)|July 1, 1995
Granulocyte colony-stimulating factor improves myelopoiesis and host defense in fulminant intra-abdominal sepsis in ratsR Lundblad, M Y Wang, G Kvalheim, et al.International Journal of Immunopathology and Pharmacology|October 6, 2004
Development of a clinical grade procedure for generation of mRNA transfected dendritic cells from purified frozen CD34(+) blood progenitor cellsL J Mu, P Lazarova, G Gaudernack, et al.Leukemia Research|January 1, 1987
Removal of cells from a malignant B-cell line from bone marrow with immunomagnetic beads and with complement and immunoglobulin switch variant mediated cytolysisS Kiesel, R Haas, G Moldenhauer, et al.Cytotherapy|August 13, 2002
CD34(+) cell enrichment depletes atypical CD30(+) cells from PBPC grafts in patients with HDA K Blystad, E Torlakovic, H Holte, et al.Pageof 7